logo Ibionextlogo Ibionext
  • HOME
  • ABOUT US
  • STRATEGY
  • TEAM
  • OUR COMPANIES
  • NEWS & MEDIA
  • CONTACT
  • Français
Twitter
LinkedIn

Category: Press releases

Home Archive by Category "Press releases" (Page 3)

Chronolife chooses Mulliez-Flory to manufacture their connected textiles on an industrial scale

December 17, 2020Press releasesIbionext

Paris, December 17th, 2020 – Chronolife, a French artificial intelligence company specializing in digital health, announced today that they have chosen the Cholet-headquartered Mulliez-Flory textile family to provide 100% integrated solutions (creation, manufacturing, distribution, recycling) for the industrial manufacturing of…

Tilak Healthcare inks a new partnership agreement in ophtalmology with Novartis to expand internationally (To promote OdySight®, an innovative vision monitoring technology)

December 8, 2020Press releasesIbionext

Paris, December 8, 2020 – Tilak Healthcare, a digital therapeutics pioneer specializing in the development of mobile medical application games used as monitoring and rehabilitation tools for chronic diseases, is proud to announce a framework agreement with Novartis Pharma AG…

Medical monitoring: Chronolife partners with be-ys to optimize remote care of patients with chronic disease

November 24, 2020Press releasesIbionext

Paris, (France) November 24th, 2020 – Chronolife, an artificial intelligence company specialized in digital health, and be-ys, expert in health data management and security, have both decided to combine their skills in order to offer healthcare professionals a turnkey service…

BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

November 23, 2020Press releasesIbionext

Paris, France, November 23th, 2020 – BrainEver, a biotechnology company dedicated to the research and development of innovative therapies for the treatment of neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation…

GrAI Matter Labs Raises $14M to Bring Fastest AI per Watt to Every Device on the Edge

November 23, 2020Press releasesIbionext

NOVEMBER 23, 2020 PARIS- GrAI Matter Labs, a pioneer of brain inspired ultra-low latency computing, today announced its latest financing round of $14 million. The round was led by iBionext, joined by all existing investors and newly welcomed Bpifrance through…

BrainEver Receives FDA Orphan Drug Designation for BREN-02, (human recombinant Engrailed 1) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

November 23, 2020Press releasesIbionext

Paris, France, November 23th, 2020 – BrainEver, a biotechnology company dedicated to the research and development of innovative therapies for the treatment of neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation…

GrAI Matter Labs Raises $14M to Bring Fastest AI per Watt to Every Device on the Edge

November 23, 2020Press releasesIbionext

NOVEMBER 23, 2020 PARIS–(BUSINESS WIRE)–GrAI Matter Labs, a pioneer of brain inspired ultra-low latency computing, today announced its latest financing round of $14 million. The round was led by iBionext, joined by all existing investors and newly welcomed Bpifrance through…

TILAK HEALTHCARE ANNOUNCES ISO 13485 CERTIFICATION FOR MEDICAL DEVICE QUALITY MANAGEMENT SYSTEMS

November 4, 2020Press releasesIbionext

L’ISO 13485 illustre l’engagement de Tilak Healthcare en matière de sécurité et de qualité de ses dispositifs médicaux.   Paris, France, le 4 novembre 2020 – TILAK HEALTHCARE, société pionnière spécialisée dans le développement de jeux mobiles avec modules médicaux destinés au suivi…

Prophesee and FRAMOS Sign an Agreement to Expand Sales and Support for Prophesee Metavision® Solutions

September 29, 2020Press releasesIbionext

Global supplier of embedded vision solutions to offer Prophesee’s products to bring breakthrough machine vision technology to Industry 4.0 and Industrial IoT markets. PARIS and MUNICH – September 29, 2020 –  Prophesee SA, inventor of the most advanced neuromorphic vision…

Coalition Innovation Santé: Chronolife, with the support of Servier, Launches in France a Non-Invasive Telemonitoring Solution for the Continuous Monitoring of Patients Suffering from Chronic Diseases

July 23, 2020Press releasesIbionext

Paris, (France) July 23rd, 2020 – As part of the Coalition Innovation Santé – Crise Sanitaire initiative, Chronolife and Servier are collaborating to accelerate the deployment of a non-invasive telemonitoring solution which aims to facilitate remote monitoring of chronic patients during the COVID-19…

Posts navigation

< 1 2 3 4 5 6 7 >

SEARCH

ARCHIVES

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

CATEGORIES

  • Events (3)
  • News (78)
  • Press releases (67)

LATEST NEWS

  • Théa partners with Tilak Healthcare to promote OdySight: First remote monitoring solution for ophthalmology June 29, 2022
  • GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE May 16, 2022
  • Rigshospitalet, the main hospital in Denmark based in Copenhagen, collaborate with Chronolife for a clinical investigation in Oncology March 31, 2022
  • Europrotect partners with Chronolife for the development and production of a device to measure physiological data, integrated into a firefighter’s intervention suit to limit the risk of thermal stress March 13, 2022
  • OdySight, first remote monitoring solution in ophthalmology to be reimbursed by the Social Security March 9, 2022

CONTACT US

74, rue du Faubourg Saint-Antoine 75012 Paris
+33 1 76 21 47 50
contact@ibionext.com

LEGAL NOTICES

  • Cookies Policy
  • Privacy Policy
  • Terms of use
© 2023 iBionext. All rights reserved